Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers.

Davy M, Bird N, Rost KL, Fuder H.

Chemotherapy. 1999 Nov-Dec;45(6):491-5.

PMID:
10567780
[PubMed - indexed for MEDLINE]
2.

Lack of effect of gemifloxacin on the steady-state pharmacokinetics of theophylline in healthy volunteers.

Davy M, Allen A, Bird N, Rost KL, Fuder H.

Chemotherapy. 1999 Nov-Dec;45(6):478-84.

PMID:
10567778
[PubMed - indexed for MEDLINE]
3.

Warfarin pharmacodynamics unaffected by cilomilast.

Kelly J, Murdoch RD, Clark DJ, Webber DM, Fuder H.

Ann Pharmacother. 2001 Dec;35(12):1535-9.

PMID:
11793614
[PubMed - indexed for MEDLINE]
4.

Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers.

Vousden M, Allen A, Lewis A, Ehren N.

Chemotherapy. 1999 Nov-Dec;45(6):485-90.

PMID:
10567779
[PubMed - indexed for MEDLINE]
5.

Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.

Vaz-da-Silva M, Almeida L, Falcão A, Soares E, Maia J, Nunes T, Soares-da-Silva P.

Clin Ther. 2010 Jan;32(1):179-92. doi: 10.1016/j.clinthera.2010.01.014.

PMID:
20171423
[PubMed - indexed for MEDLINE]
6.

Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers.

Allen A, Vousden M, Lewis A.

Chemotherapy. 1999 Nov-Dec;45(6):496-503.

PMID:
10567781
[PubMed - indexed for MEDLINE]
7.

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.

Ragueneau-Majlessi I, Levy RH, Meyerhoff C.

Epilepsy Res. 2001 Nov;47(1-2):55-63.

PMID:
11673021
[PubMed - indexed for MEDLINE]
8.

Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.

Allen A, Bygate E, Vousden M, Oliver S, Johnson M, Ward C, Cheon A, Choo YS, Kim I.

Antimicrob Agents Chemother. 2001 Feb;45(2):540-5.

PMID:
11158752
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.

Schwartz JI, Bugianesi KJ, Ebel DL, De Smet M, Haesen R, Larson PJ, Ko A, Verbesselt R, Hunt TL, Lins R, Lens S, Porras AG, Dieck J, Keymeulen B, Gertz BJ.

Clin Pharmacol Ther. 2000 Dec;68(6):626-36.

PMID:
11180023
[PubMed - indexed for MEDLINE]
10.

Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin.

Depré M, Van Hecken A, Oeyen M, De Lepeleire I, Laethem T, Rothenberg P, Petty KJ, Majumdar A, Crumley T, Panebianco D, Bergman A, de Hoon JN.

Eur J Clin Pharmacol. 2005 Jul;61(5-6):341-6. Epub 2005 Jun 28.

PMID:
15983826
[PubMed - indexed for MEDLINE]
11.

Eprosartan does not affect the pharmacodynamics of warfarin.

Kazierad DJ, Martin DE, Ilson B, Boike S, Zariffa N, Forrest A, Jorkasky DK.

J Clin Pharmacol. 1998 Jul;38(7):649-53.

PMID:
9702851
[PubMed - indexed for MEDLINE]
12.

Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.

Vakily M, Lee RD, Wu J, Gunawardhana L, Mulford D.

Clin Drug Investig. 2009;29(1):35-50. doi: 10.2165/0044011-200929010-00004.

PMID:
19067473
[PubMed - indexed for MEDLINE]
13.

The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.

Parra D, Beckey NP, Stevens GR.

Pharmacotherapy. 2007 May;27(5):675-83.

PMID:
17461702
[PubMed - indexed for MEDLINE]
14.

Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers.

Allen A, Bygate E, Oliver S, Johnson M, Ward C, Cheon AJ, Choo YS, Kim IC.

Antimicrob Agents Chemother. 2000 Jun;44(6):1604-8.

PMID:
10817716
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Irbesartan does not affect the steady-state pharmacodynamics and pharmacokinetics of warfarin.

Mangold B, Gielsdorf W, Marino MR.

Eur J Clin Pharmacol. 1999 Oct;55(8):593-8.

PMID:
10541778
[PubMed - indexed for MEDLINE]
16.

Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.

Yu CY, Campbell SE, Zhu B, Knadler MP, Small DS, Sponseller CA, Hunt TL, Morgan RE.

Curr Med Res Opin. 2012 Feb;28(2):187-94. doi: 10.1185/03007995.2011.648264. Epub 2012 Jan 9.

PMID:
22149769
[PubMed - indexed for MEDLINE]
17.

Voriconazole potentiates warfarin-induced prothrombin time prolongation.

Purkins L, Wood N, Kleinermans D, Nichols D.

Br J Clin Pharmacol. 2003 Dec;56 Suppl 1:24-9.

PMID:
14616410
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin.

Vousden M, Ferguson J, Richards J, Bird N, Allen A.

Chemotherapy. 1999 Nov-Dec;45(6):512-20.

PMID:
10567783
[PubMed - indexed for MEDLINE]
19.

Effects of duloxetine on the pharmacodynamics and pharmacokinetics of warfarin at steady state in healthy subjects.

Chappell J, He J, Knadler MP, Mitchell M, Lee D, Lobo E.

J Clin Pharmacol. 2009 Dec;49(12):1456-66. doi: 10.1177/0091270009344335. Epub 2009 Sep 30.

PMID:
19793910
[PubMed - indexed for MEDLINE]
20.

Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects.

Jindal D, Tandon M, Sharma S, Pillai KK.

Eur J Clin Pharmacol. 2005 Oct;61(9):621-5. Epub 2005 Oct 19.

PMID:
16133549
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk